Related Experiment Video
Updated: Jun 21, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Patient self-management of oral anticoagulation
Tonya L Fancher1, Richard H White
1Division of General Medicine, University of California, Davis Patient Support Services Building, Suite 2400, Sacramento, CA 95817, USA. tlfancher@ucdavis.edu
Abstract:
More than six million patients worldwide are being treated with an oral anticoagulant. Dosing of the anticoagulant is usually managed by a primary care physician, cardiologist, or a specialized anticoagulation clinic. With the introduction of point-of-care testing devices, it is possible for patients to monitor their coagulation time, the international normalized ratio, at home. Selected patients, when properly trained, are capable of managing their oral anticoagulation treatment from home, so-called patient self-management (PSM). PSM has been practiced for many years in Europe, where training centers and reimbursement are well established. Because the US Center for Medicare and Medicaid Services recently decided to cover PSM, the practice will likely become more common in the United States. This article reviews the evidence behind the efficacy, safety, and cost effectiveness of PSM.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism III: Nursing Management

